Cargando…

Hyperuricemia and Hypertension, Coronary Artery Disease, Kidney Disease: From Concept to Practice

Since the publication of the Framingham Heart Study, which suggested that uric acid should no longer be associated with coronary heart disease after additional adjustment for cardiovascular disease risk factors, the number of publications challenging this statement has dramatically increased. The ai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gaubert, Mélanie, Bardin, Thomas, Cohen-Solal, Alain, Diévart, François, Fauvel, Jean-Pierre, Guieu, Régis, Sadrin, Stéphane, Maixent, Jean Michel, Galinier, Michel, Paganelli, Franck
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312288/ https://www.ncbi.nlm.nih.gov/pubmed/33561034 http://dx.doi.org/10.3390/ijms21114066

Ejemplares similares

Adenosine and Its Receptors: An Expected Tool for the Diagnosis and Treatment of Coronary Artery and Ischemic Heart Diseases
por: Gaudry, Marine, et al.
Publicado: (2020)

Extracellular vesicles with ubiquitinated adenosine A(2A) receptor in plasma of patients with coronary artery disease
por: Ruf, Jean, et al.
Publicado: (2019)

Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link?
por: Paganelli, Franck, et al.
Publicado: (2021)

Adenosine Receptor Reserve and Long-Term Potentiation: Unconventional Adaptive Mechanisms in Cardiovascular Diseases?
por: Guieu, Régis, et al.
Publicado: (2021)

Adenosine Receptor Profiling Reveals an Association between the Presence of Spare Receptors and Cardiovascular Disorders
por: Fenouillet, Emmanuel, et al.
Publicado: (2019)

Homocysteine concentration and adenosine A(2A) receptor production by peripheral blood mononuclear cells in coronary artery disease patients
por: Deharo, Pierre, et al.
Publicado: (2020)

Safety of Desmodium adscendens extract on hepatocytes and renal cells. Protective effect against oxidative stress
por: François, Céline, et al.
Publicado: (2014)

Specific Pharmacological Profile of A(2A) Adenosine Receptor Predicts Reduced Fractional Flow Reserve in Patients With Suspected Coronary Artery Disease
por: Paganelli, Franck, et al.
Publicado: (2018)

Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection
por: Kielstein, Jan T., et al.
Publicado: (2020)

Biological Activities and Polyphenol Content of Qi Cha Tea(®), a Functional Beverage of White Tea Containing Botanicals and Dry Botanical Extracts with European Health Claims
por: Maixent, Jean Michel, et al.
Publicado: (2023)

Dysuricemia—A New Concept Encompassing Hyperuricemia and Hypouricemia
por: Otani, Naoyuki, et al.
Publicado: (2023)

Blood pressure and proteinuria control remains a challenge in patients with type 2 diabetes mellitus and chronic kidney disease: experience from the prospective observational ALICE-PROTECT study
por: Halimi, Jean-Michel, et al.
Publicado: (2016)

Hyperoxia Improves Hemodynamic Status During Head-up Tilt Testing in Healthy Volunteers: A Randomized Study
por: Fromonot, Julien, et al.
Publicado: (2016)

Hyperuricemia in Patients With Coronary Artery Disease and Its Association With Disease Severity
por: Padda, Jaskamal, et al.
Publicado: (2021)

Effect of Brewing Duration on the Antioxidant and Hepatoprotective Abilities of Tea Phenolic and Alkaloid Compounds in a t-BHP Oxidative Stress-Induced Rat Hepatocyte Model
por: Braud, Laura, et al.
Publicado: (2015)

Conceptions of inquiry
por: Brown, Stuart, et al.
Publicado: (1981)

Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM)
por: Gourdy, Pierre, et al.
Publicado: (2023)

Area-Specific Alterations of Synaptic Plasticity in the 5XFAD Mouse Model of Alzheimer’s Disease: Dissociation between Somatosensory Cortex and Hippocampus
por: Crouzin, Nadine, et al.
Publicado: (2013)

Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis
por: Cautela, Jennifer, et al.
Publicado: (2020)

Diagnostic Value of the International Society of Cardio‐Oncology Definition for Suspected Immune Checkpoint Inhibitor–Associated Myocarditis
por: Deharo, Francois, et al.
Publicado: (2023)

Allopurinol for prevention of progression of kidney disease with hyperuricemia
por: Pai, B. H. Santhosh, et al.
Publicado: (2013)

The grey zone of Hyperuricemia in chronic kidney disease
por: Dousdampanis, Periklis
Publicado: (2017)

Hyperuricemia and chronic kidney disease: to treat or not to treat
por: Piani, Federica, et al.
Publicado: (2021)

Association of anti-hyperuricemia treatment and prevalent cardiovascular disease in hypertensive patients
por: Zeng, Fanfang, et al.
Publicado: (2019)

Hyperuricemia and Hypertension: Links and Risks
por: Stewart, Douglas J, et al.
Publicado: (2019)

High incidence of atrial fibrillation in patients treated with ibrutinib
por: Baptiste, Florian, et al.
Publicado: (2019)

Improvement of Young and Elderly Patient’s Knowledge of Heart Failure After an Educational Session
por: Roncalli, Jérôme, et al.
Publicado: (2009)

Effects of Physical Exercise on Cardiovascular Diseases: Biochemical, Cellular, and Organ Effects
por: Crisafulli, Antonio, et al.
Publicado: (2015)

Bone Fragility in Chronic Kidney Disease Stage 3 to 5: The Use of Vitamin D Supplementation
por: Ureña Torres, Pablo Antonio, et al.
Publicado: (2022)

Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease
por: Akimoto, Tetsu, et al.
Publicado: (2014)

To treat or not to treat asymptomatic hyperuricemia in chronic kidney disease
por: Shin, Dong Ho
Publicado: (2019)

Role of asymptomatic hyperuricemia in the progression of chronic kidney disease and cardiovascular disease
por: Waheed, Yousuf, et al.
Publicado: (2021)

Hyperuricemia and Its Association With Ischemic Stroke
por: Padda, Jaskamal, et al.
Publicado: (2021)

Non‐alcoholic fatty liver disease and heart failure with preserved ejection fraction: from pathophysiology to practical issues
por: Itier, Romain, et al.
Publicado: (2021)

Plasma A(2A)R Measurement Can Help Physicians Identify Patients Suspected of Coronary Chronic Syndrome: A Pilot Study
por: Paganelli, Franck, et al.
Publicado: (2022)

Management of Immune Checkpoint Inhibitor–Induced Myocarditis: The French Working Group’s Plea for a Pragmatic Approach
por: Thuny, Franck, et al.
Publicado: (2021)

Méthodologie de Conception de Cartes Rapides: Workshop
por: Sainson, Jean-Michel
Publicado: (2003)

Associations Between Hyperuricemia and Chronic Kidney Disease: A Review
por: Prasad Sah, Om Shankar, et al.
Publicado: (2015)

Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview
por: Chen, Changyi, et al.
Publicado: (2016)

Association of hyperuricemia with disease severity in chronic hepatitis C patients
por: Jang, Tyng-Yuan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5pfm3s7j6b4a97s6b0i8uklomp